Enhabit (NYSE:EHAB) Releases FY 2024 Earnings Guidance

Enhabit (NYSE:EHAB) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.190-0.370 for the period, compared to the consensus estimate of 0.270. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Analyst Upgrades and Downgrades

EHAB has been the topic of a number of recent research reports. Leerink Partnrs upgraded shares of Enhabit from a strong sell rating to a hold rating in a research note on Tuesday, May 14th. Jefferies Financial Group cut shares of Enhabit from a buy rating to a hold rating and lowered their target price for the company from $14.00 to $8.75 in a research note on Thursday, May 9th. SVB Leerink raised Enhabit from an underperform rating to a market perform rating and set a $8.50 price objective on the stock in a report on Tuesday, May 14th. Finally, Bank of America lowered their price objective on Enhabit from $9.00 to $8.00 and set an underperform rating on the stock in a research note on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the company. According to MarketBeat, the company has an average rating of Hold and a consensus target price of $9.79.

Enhabit Stock Up 3.1 %

EHAB traded up $0.30 during trading on Tuesday, hitting $9.90. The company had a trading volume of 454,042 shares, compared to its average volume of 559,921. The firm’s 50-day moving average price is $9.23 and its 200 day moving average price is $9.69. The company has a market capitalization of $496.54 million, a PE ratio of -5.96, a PEG ratio of 1.58 and a beta of 1.85. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.75. Enhabit has a one year low of $7.12 and a one year high of $14.22.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. Enhabit had a positive return on equity of 1.43% and a negative net margin of 7.95%. The company had revenue of $262.40 million for the quarter, compared to analyst estimates of $268.25 million. As a group, equities analysts expect that Enhabit will post 0.24 earnings per share for the current year.

Insiders Place Their Bets

In other Enhabit news, Director Jeffrey Bolton purchased 10,000 shares of the company’s stock in a transaction dated Friday, May 17th. The stock was bought at an average cost of $8.33 per share, for a total transaction of $83,300.00. Following the completion of the transaction, the director now owns 52,299 shares in the company, valued at $435,650.67. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders acquired 22,000 shares of company stock worth $183,700 in the last quarter. 1.90% of the stock is currently owned by corporate insiders.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.